KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Debt Ratio (2018 - 2026)

Castle Biosciences' Debt Ratio history spans 6 years, with the latest figure at 0.02 for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 7.87% to 0.02 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.02, a 7.87% decrease, with the full-year FY2025 number at 0.02, down 7.87% from a year prior.
  • Debt Ratio hit 0.02 in Q4 2025 for Castle Biosciences, down from 0.02 in the prior quarter.
  • Over the last five years, Debt Ratio for CSTL hit a ceiling of 0.05 in Q1 2022 and a floor of 0.02 in Q4 2025.
  • Historically, Debt Ratio has averaged 0.02 across 3 years, with a median of 0.02 in 2024.
  • The widest YoY moves for Debt Ratio: up 7.87% in 2025, down 10.25% in 2025.
  • Tracing CSTL's Debt Ratio over 3 years: stood at 0.05 in 2022, then plummeted by 59.78% to 0.02 in 2024, then decreased by 7.87% to 0.02 in 2025.
  • Business Quant data shows Debt Ratio for CSTL at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.02 in Q2 2025.